An update on long intergenic noncoding RNA p21: a regulatory molecule with various significant functions in cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An update on long intergenic noncoding RNA p21: a regulatory molecule with various significant functions in cancer
Authors
Keywords
-
Journal
Cell and Bioscience
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-22
DOI
10.1186/s13578-020-00445-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma
- (2019) Shufang Jin et al. Molecular Cancer
- LincRNA-p21 leads to G1 arrest by p53 pathway in esophageal squamous cell carcinoma
- (2019) Ying Zhang et al. Cancer Management and Research
- MYEOV functions as an amplified competing endogenous RNA in promoting metastasis by activating TGF-β pathway in NSCLC
- (2018) Lishan Fang et al. ONCOGENE
- A lincRNA-p21/miR-181 family feedback loop regulates microglial activation during systemic LPS- and MPTP- induced neuroinflammation
- (2018) Yongyi Ye et al. Cell Death & Disease
- Long intergenic noncoding RNA-p21 inhibits apoptosis by decreasing PUMA expression in non-small cell lung cancer
- (2018) Tao Yang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Long noncoding RNA-p21 modulates cellular senescence via the Wnt/β-catenin signaling pathway in mesenchymal stem cells
- (2017) Wenzheng Xia et al. Molecular Medicine Reports
- LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism
- (2017) Gangqiang Ding et al. OncoTargets and Therapy
- Down regulation of lincRNA-p21 contributes to gastric cancer development through Hippo-independent activation of YAP
- (2017) Ying Chen et al. Oncotarget
- Long intragenic non-coding RNA lincRNA-p21 suppresses development of human prostate cancer
- (2016) Xiaohai Wang et al. CELL PROLIFERATION
- PUMA and survivin are involved in the apoptosis of HepG2 cells induced by microcystin-LR via mitochondria-mediated pathway
- (2016) Junguo Ma et al. CHEMOSPHERE
- lincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through Notch signaling-induced epithelial-mesenchymal transition
- (2016) Meng Jia et al. HEPATOLOGY RESEARCH
- LincRNA-p21 Impacts Prognosis in Resected Non–Small Cell Lung Cancer Patients through Angiogenesis Regulation
- (2016) Joan J. Castellano et al. Journal of Thoracic Oncology
- The cross talk between long, non-coding RNAs and microRNAs in gastric cancer
- (2015) Kaiyuan Deng et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy
- (2015) Wei Peng et al. CLINICAL AND EXPERIMENTAL MEDICINE
- LincRNA-p21: Implications in Human Diseases
- (2015) Sai-Sai Tang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- p53-dependent non-coding RNA networks in chronic lymphocytic leukemia
- (2015) C J Blume et al. LEUKEMIA
- LincRNA-p21 acts as a mediator of ING1b-induced apoptosis
- (2015) U M Tran et al. Cell Death & Disease
- Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes
- (2015) J R Hall et al. Cell Death & Disease
- miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells
- (2015) Jun Wang et al. Oncotarget
- The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters
- (2014) Xichen Bao et al. CELL RESEARCH
- LincRNA-p21 Regulates Neointima Formation, Vascular Smooth Muscle Cell Proliferation, Apoptosis, and Atherosclerosis by Enhancing p53 Activity
- (2014) Gengze Wu et al. CIRCULATION
- Investigation of circulating lncRNAs in B-cell neoplasms
- (2014) Mustafa Isin et al. CLINICA CHIMICA ACTA
- LincRNA-p21 Activates p21 In cis to Promote Polycomb Target Gene Expression and to Enforce the G1/S Checkpoint
- (2014) Nadya Dimitrova et al. MOLECULAR CELL
- HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression
- (2014) S-D Chou et al. ONCOGENE
- LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway
- (2014) GUANGYU WANG et al. ONCOLOGY REPORTS
- Clinical Significance of Long Intergenic Noncoding RNA-p21 in Colorectal Cancer
- (2013) Haiyan Zhai et al. Clinical Colorectal Cancer
- Reciprocal Regulation of HIF-1α and LincRNA-p21 Modulates the Warburg Effect
- (2013) Fan Yang et al. MOLECULAR CELL
- Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells
- (2012) Emre Özgür et al. CLINICAL AND EXPERIMENTAL MEDICINE
- MS2-TRAP (MS2-tagged RNA affinity purification): Tagging RNA to identify associated miRNAs
- (2012) Je-Hyun Yoon et al. METHODS
- LincRNA-p21 Suppresses Target mRNA Translation
- (2012) Je-Hyun Yoon et al. MOLECULAR CELL
- A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
- (2011) Marcella Cesana et al. CELL
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
- (2011) Leonardo Salmena et al. CELL
- Molecular Mechanisms of Long Noncoding RNAs
- (2011) Kevin C. Wang et al. MOLECULAR CELL
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
- (2010) Maite Huarte et al. CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started